Center for Adaptation Genetics and Drug Resistance, Tufts University School of Medicine, Boston, Massachusetts, USA.
Antimicrob Agents Chemother. 2013 Apr;57(4):1935-7. doi: 10.1128/AAC.02445-12. Epub 2013 Jan 14.
A carbapenem-resistant clinical isolate of Escherichia coli, which lacked OmpF and OmpC porins, carried a marR mutation and expressed a functional yedS, a normally nontranslated gene. MarR and YedS are described here as having effects on the ability of this strain to resist carbapenems. Additionally, expression of YedS was regulated by the small RNA MicF in a MarA-dependent way. These findings illustrate how broadly bacteria can mutate within a selective clinical setting, in this case, resistance to carbapenems, by altering three porin genes and one regulatory gene.
一株缺乏 OmpF 和 OmpC 孔蛋白的耐碳青霉烯临床分离大肠埃希菌,携带 marR 突变,并表达了一个有功能的 yedS,这是一个通常不翻译的基因。MarR 和 YedS 在这里被描述为对该菌株抵抗碳青霉烯的能力有影响。此外,YedS 的表达受 MarA 依赖性小 RNA MicF 的调控。这些发现说明了在选择性临床环境中,细菌可以通过改变三个孔蛋白基因和一个调节基因,在这种情况下是对碳青霉烯的耐药性,发生多么广泛的突变。